We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.3B
AUM Growth
+$1.15B
Cap. Flow
-$471M
Cap. Flow %
-1.46%
Top 10 Hldgs %
14.89%
Holding
3,376
New
63
Increased
922
Reduced
1,973
Closed
392

Top Sells

Rank Stock Value
1
NWSA icon
News Corp Class A
NWSA
+$44.5M
2
S
Sprint Corporation
S
+$26.1M
3
DIS icon
Walt Disney
DIS
+$14.9M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
BMC
BMC SOFTWARE, INC
BMC
+$10.7M

Sector Composition

Rank Sector Weight
1 Financials 14.98%
2 Technology 13.8%
3 Healthcare 12.57%
4 Industrials 11.2%
5 Energy 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
2951
Cytokinetics
CYTK
$10.4B
$78K ﹤0.01%
10,277
-223
-2% -$2.39K
NSPH
2952
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$76K ﹤0.01%
1,907
-20
-1% -$998
CORT icon
2953
Corcept Therapeutics
CORT
$12.2B
$74K ﹤0.01%
46,305
-491
-1% -$866
DS
2954
DELISTED
Drive Shack Inc.
DS
$74K ﹤0.01%
14,565
PCYO icon
2955
Pure Cycle
PCYO
$258M
$68K ﹤0.01%
14,759
-171
-1% -$927
FOLD
2956
DELISTED
Amicus Therapeutics
FOLD
$67K ﹤0.01%
28,706
-267
-0.9% -$670
BIOL
2957
DELISTED
Biolase, Inc.
BIOL
$67K ﹤0.01%
3
+1
+50% +$32.2K
FCSC
2958
DELISTED
Fibrocell Science Inc.
FCSC
$65K ﹤0.01%
983
-11
-1% -$889
ALIM
2959
DELISTED
Alimera Sciences
ALIM
$61K ﹤0.01%
1,087
-4
-0.4% -$251
STRP
2960
DELISTED
Straight Path Communications Inc.
STRP
$60K ﹤0.01%
+11,338
New +$58.9K
TGTX icon
2961
TG Therapeutics
TGTX
$7.07B
$59K ﹤0.01%
11,546
+376
+3% +$2.3K
BXC icon
2962
BlueLinx
BXC
$471M
$57K ﹤0.01%
2,934
-30
-1% -$569
AMRS
2963
DELISTED
Amyris Inc.
AMRS
$57K ﹤0.01%
1,648
-16
-1% -$650
KSPN
2964
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$56K ﹤0.01%
605
-150
-20% -$14.6K
XBKS
2965
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$56K ﹤0.01%
3,949
-1,026
-21% -$16.6K
PTX
2966
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$55K ﹤0.01%
2,007
-416
-17% -$13.4K
LLEN
2967
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$52K ﹤0.01%
40,733
-277
-0.7% -$754
ONCT
2968
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$51K ﹤0.01%
18
ZAZA
2969
DELISTED
ZAZA ENERGY CORP COM NEW
ZAZA
$41K ﹤0.01%
3,561
-35
-1% -$390
VATE icon
2970
INNOVATE Corp
VATE
$99.6M
$36K ﹤0.01%
1,052
-14
-1% -$1.27K
PLPM
2971
DELISTED
Planet Payment, Inc
PLPM
$34K ﹤0.01%
13,368
-552
-4% -$1.43K
VRTB
2972
DELISTED
Vestin Realty Mortgage II, Inc.
VRTB
$23K ﹤0.01%
3,400
FMAR
2973
DELISTED
FIRST MARINER BANCORP
FMAR
$17K ﹤0.01%
22,600
ULU
2974
DELISTED
ULURU INC COM STK NEW (NV)
ULU
$9K ﹤0.01%
22,000
GMET
2975
DELISTED
GEOMET INC COM STK
GMET
$5K ﹤0.01%
39,097

Similar funds

RhumbLine Advisers's Q3 2013 Portfolio in Review

As of Q3 2013, RhumbLine Advisers held 3,376 positions worth $32.3B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q3 2013 filing shows 63 new, 922 increased, 1,973 reduced and 392 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 3,584,349 shares worth $120M. The largest sale was News Corp Class A, an estimated $44.5M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 3,584,349 shares worth $120M.
  • RhumbLine Advisers added most to Chubb in Q3 2013, an estimated $8.73M increase.
  • RhumbLine Advisers's biggest Q3 2013 reduction was News Corp Class A, cutting an estimated $44.5M.
  • RhumbLine Advisers fully exited BMC SOFTWARE, INC in Q3 2013, selling an estimated $10.7M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $32.3B portfolio in Q3 2013.
  • RhumbLine Advisers opened 63 new positions and closed 392 in Q3 2013.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2013, filed 5 Nov 2013.